MetaCap

Privia Health Group Inc. (PRVA)

NASDAQ: PRVAHealth CareMedical/Nursing ServicesUSD

25.05+0.36 (+1.46%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

PRVA stock chart

Technical analysis

Key statistics

All statistics
52-week range
18.92 – 28.82
Day range
24.52 – 25.40
Volume / Avg
1.93M / 1.33M
Beta
—

52-week range

$18.92$28.82

PRVA stock today

Shares of Privia Health Group (PRVA) finished higher on Nov 20 at $25.05, a gain of 1.46% or $0.36 per share, versus the S&P 500's 3.70% decline. Shares are 13.1% below their 52-week high of $28.82, set on Jul 16, 2026 and 32.4% above the 52-week low of $18.92, in the middle of the past year's range. PRVA is up 5.7% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 5.5%.

At 96.3x trailing earnings, Privia Health Group trades above the peer-group median of 21.6x. Its forward P/E of 23.1x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year.

Summary generated from market data by MetaCap's automated system. Methodology

About Privia Health Group

Company profile

Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with physician practices, health plans, and health systems.

Industry
Medical/Nursing Services
CEO
Mr. Parth Mehrotra
Headquarters
Arlington, VA
Employees
1,226
IPO year
2021

Financial highlights

Full financials

In fiscal 2025, Privia Health Group generated $2.12 billion in revenue, up 22.3% from fiscal 2024, its 6th consecutive year of revenue growth. Net income was $22.9 million (+59.3% year over year), for a net margin of 1.1% versus a median of 0.8% in the prior 5 years. Operating margin was 1.6%.

Privia Health Group annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$2.12B$1.74B$1.66B$1.36B$966.22M
Growth+22.26%+4.74%+22.19%+40.41%+18.25%
Net income$22.92M$14.38M$23.08M$-8.59M$-188.23M
EPS (diluted)$0.18$0.11$0.19$-0.08$-1.83

Analyst forecast

Forecast

Consensus (18 analysts)

strong_buy

Avg. price target

$31.35+25.15%

  • Strong buy 5
  • Buy 12
  • Hold 1
  • Sell 0
  • Strong sell 0

Target range

Low $24.00High $38.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 5, 2026
EPS actual vs est.
$0.10 vs $0.09
Surprise
+11.11%

PRVA news

All PRVA news

Privia Health Group peers

Health Care sector
PRVA peer companies
CompanyPrice% ChgMarket capCompare
HIMSHims & Hers Health Inc. Class A14.60-8.86%$3.42Bvs PRVA
AVAHAveanna Healthcare Holdings Inc.11.01+2.90%$2.40Bvs PRVA
ADUSAddus HomeCare Corporation122.50+1.18%$2.28Bvs PRVA
OPCHOption Care Health Inc.31.59-0.06%$4.73Bvs PRVA
USPHU.S. Physical Therapy Inc.95.93+1.71%$1.43Bvs PRVA
WGSGeneDx Holdings Corp. Class A45.46-7.68%$1.36Bvs PRVA
TDOCTeladoc Health Inc.7.45-4.36%$1.36Bvs PRVA
INNVInnovAge Holding Corp.9.16+2.81%$1.25Bvs PRVA

Indexes, lists and sector

Privia Health Group stock FAQ

What is Privia Health Group's stock price today?

PRVA last traded at $25.05 as of Nov 20, 4:00 PM EST, up 1.46% on the day. Prices are delayed at least 15 minutes.

What is PRVA's P/E ratio?

PRVA trades at a trailing P/E ratio of 96.35 and a forward P/E of 23.08, compared with a median of 21.6 for its closest peers.

Who is Privia Health Group's CEO?

Mr. Parth Mehrotra is the chief executive officer of Privia Health Group Inc., which has about 1,226 employees.

What is the PRVA 52-week high?

The 52-week high for PRVA is $28.82 and the 52-week low is $18.92. The stock is currently 13.1% below its high.

Compare PRVA